Biotech

All Articles

Biogen's CEO mentioned no unsafe deals in 2023. He prepares to become bold

.While Biogen's pharma peers are actually seeking for late-stage properties along with little risk, ...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Bio has been actually a biotech in search of a pipeline after it scrapped its lead assets ov...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored rights to an early Alzheimer's disease course to Denali Therapeutics, ...

Takeda taps brand-new mind of US oncology organization-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable management hirings, firings as ...

Vertex, beaten through AATD once more, drops 2 assets on discard heap

.Tip's effort to deal with an unusual genetic condition has actually attacked another problem. The b...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of personnel

.Vir Biotechnology's second-quarter profits document wasn't short of major updates. The provider wel...

Galapagos stops briefly CAR-T cell therapy litigation over Parkinsonism instance

.Galapagos has actually paused registration in a test of a BCMA-directed CAR-T cell therapy, pushing...

James Wilson leaving Penn to release two new biotechs

.After more than 30 years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leaving behind ...

3 biotechs try to trump the summertime warm through shedding workers

.As biotechs seek to turn a new web page in August, at least three business have actually dropped te...

venBio raises $528M for 5th lifestyle sciences VC fund

.Expert venture capital firm venBio has actually lifted another half a billion bucks to purchase bio...